Comment on: Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance
2008
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
3
References
2
Citations
NaN
KQI